Cidara Therapeutics Inc (CDTX) — Cash Flow Quality Index

Latest as of March 2023: -3.62x

Cidara Therapeutics Inc (CDTX) has a Cash Flow Quality Index of -3.62x as of March 2023. Operating cash flow of $-10.90 Million is below net income of $3.01 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Cidara Therapeutics Inc (CDTX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-3.62x

Operating CF / Net Income

Operating Cash Flow

$-10.90 Million

USD

Net Income

$3.01 Million

USD

Data as of

Mar 2023

Most recent filing

Annual Cash Flow Quality Index for Cidara Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Cidara Therapeutics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.